News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,295 Results
Type
Article (88745)
Company Profile (816)
Press Release (793713)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233575)
Career Advice (4162)
Deals (39981)
Drug Delivery (177)
Drug Development (91688)
Employer Resources (207)
FDA (18551)
Job Trends (17484)
News (398697)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
Adcomms (40)
Allergies (192)
Alliances (56989)
ALS (234)
Alzheimer's disease (1962)
Antibody-drug conjugate (ADC) (548)
Approvals (18881)
Artificial intelligence (858)
Autoimmune disease (351)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (247)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6518)
Cardiovascular disease (548)
Career advice (3597)
Career pathing (52)
CAR-T (380)
CDC (76)
Celiac Disease (3)
Cell therapy (1060)
Cervical cancer (53)
Clinical research (78899)
Collaboration (2341)
Company closure (8)
Compensation (1503)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1264)
Cystic fibrosis (167)
Data (8590)
Decentralized trials (3)
Denatured (90)
Depression (192)
Dermatology (96)
Diabetes (677)
Diagnostics (7584)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (419)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102476)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138473)
Executive appointments (1186)
FDA (22582)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1916)
Gene editing (269)
Generative AI (89)
Gene therapy (845)
GLP-1 (1270)
Government (5556)
Grass and pollen (8)
Guidances (419)
Healthcare (21248)
HIV (92)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (351)
Immuno-oncology (114)
Indications (201)
Infectious disease (3433)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (314)
Interviews (821)
IPO (17997)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (53)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (868)
Lymphoma (460)
Machine learning (66)
Management (66)
Manufacturing (1207)
MASH (221)
Medical device (15266)
Medtech (15416)
Mergers & acquisitions (23265)
Metabolic disorders (1779)
mRNA (263)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (500)
Neuropsychiatric disorders (126)
Neuroscience (3690)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5142)
Now hiring (80)
Obesity (852)
Opinion (373)
Ovarian cancer (242)
Pain (281)
Pancreatic cancer (343)
Parkinson's disease (412)
Partnered (39)
Patents (645)
Patient recruitment (735)
Peanut (69)
People (67935)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24386)
Phase 2 (34273)
Phase 3 (25770)
Pipeline (9594)
Policy (396)
Postmarket research (3559)
Preclinical (10963)
Press Release (72)
Prostate cancer (342)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1245)
Real estate (7462)
Recruiting (81)
Regulatory (30327)
Reports (77)
Research institute (2768)
Resumes & cover letters (654)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (195)
Series A (324)
Series B (232)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (144)
Tariffs (104)
The Weekly (143)
Vaccines (1299)
Venture capital (131)
Weight loss (584)
Women's health (139)
Worklife (24)
Date
Today (55)
Last 7 days (831)
Last 30 days (3117)
Last 365 days (33104)
2026 (15657)
2025 (33219)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52253)
Australia (9187)
California (14276)
Canada (3988)
China (1549)
Colorado (612)
Connecticut (636)
Delaware (440)
Europe (120491)
Florida (2116)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1235)
India (102)
Indiana (659)
Iowa (25)
Japan (583)
Kansas (143)
Kentucky (56)
Louisiana (54)
Maine (89)
Maryland (1734)
Massachusetts (10429)
Michigan (421)
Minnesota (795)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3783)
New Mexico (35)
New York (3752)
North Carolina (1926)
North Dakota (11)
Northern California (7088)
Ohio (443)
Oklahoma (26)
Oregon (55)
Pennsylvania (2819)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5601)
Tennessee (225)
Texas (2323)
United States (51062)
Utah (425)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1176)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,295 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Merck continues New Jersey cuts, laying off 88 in Rahway
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
June 8, 2026
·
57 min read
·
BioSpace Editorial Staff
Press Releases
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
June 8, 2026
·
5 min read
Press Releases
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
June 8, 2026
·
7 min read
FDA
Post-Makary, new rare disease framework faces fresh uncertainty
As the FDA tries to clarify its intent for former FDA Commissioner Marty Makary’s plausible mechanism framework for bespoke therapies, experts emphasize the importance of expanding its scope to encompass rare diseases that affect more than just one or a few individuals.
June 8, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
June 7, 2026
·
15 min read
Press Releases
Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026
June 7, 2026
·
5 min read
Press Releases
OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
June 7, 2026
·
6 min read
Press Releases
Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions
June 7, 2026
·
6 min read
Press Releases
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
June 7, 2026
·
4 min read
Press Releases
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 7, 2026
·
5 min read
1 of 88,330
Next
